What’s blowing up, who’s driving it, and what it means for the market.
The state's 2025 Youth Risk Behavior Survey shows past-30-day smokeless use rising from 3% to 7% among high schoolers, while vaping declined. Health officials point to nicotine pouches: easy to hide, 'tobacco-free' on the label.
The American YouTube creator visited Nikoteket in Stockholm and filmed teenagers saying they had used snus since age 12. Tobaksfakta asked the authorities — and the Consumer Agency explained exactly how far Swedish law reaches.
The FDA is recruiting new scientific and consumer members for its advisory committees, which provide independent input on tobacco products including nicotine pouches.
A new Oxford Economics report shows illicit cigarette market share jumped from 18% to 43% between 2015 and 2025 as taxes rose. The same pressure is building for pouches.
Elitecon just signed a $60 million South African tobacco export agreement covering cigarettes, cut tobacco, and FMCG. Nicotine pouches? Not on the list.
Philip Morris International hiked its annual dividend to $6.40 per share, an 8.8% increase driven largely by its nicotine pouch business. The company has now raised payouts 248% since going public.
At this year's Global Tobacco & Nicotine Forum, the message was blunt: new pouch tech means nothing if regulators won't clear it for market.
Nicotine pouch brand LUCY signed a multi-year deal with TheBurntPeanut — 2.4 million Twitch followers — embedding LUCY Breakers into a custom holster on his 3D character model across six platforms. It is not a sponsored segment. It is canon. And it lands as regulators in the UK and US are shutting the traditional advertising doors pouch brands used to walk through.
A week-long test of Pablo's Blue Raspberry pouch found an "explosive" initial flavor hit that reviewers say can't be repeated quickly — raising questions about how extreme flavor engineering affects user experience.
Ultra raised $11M and sold 1 million cans in six months. Blip landed in 7,000+ stores. The pouch format Zyn made mainstream is now the delivery mechanism for nootropics, not nicotine.